Detalhe da pesquisa
1.
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Cytotherapy
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583170
2.
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(22): 2091-2102, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343890
3.
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
N Engl J Med
; 377(6): 523-533, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578601
4.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 19(7): 975-986, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880291
5.
Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
N Engl J Med
; 377(18): 1792-3, 2017 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091556
6.
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
Lancet
; 379(9810): 39-46, 2012 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093187
7.
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
Lancet
; 377(9768): 813-22, 2011 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21353695
8.
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
N Engl J Med
; 361(8): 745-55, 2009 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19671656
9.
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis.
Sci Rep
; 10(1): 8753, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472001
10.
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
J Urol
; 182(6): 2670-5, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19836774
11.
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Eur J Cancer
; 120: 20-30, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446213
12.
Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases.
BJU Int
; 101(9): 1071-5, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18070191
13.
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.
Adv Ther
; 35(11): 1945-1964, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324586
14.
Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.
J Clin Oncol
; 23(15): 3314-21, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15738536
15.
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
J Clin Oncol
; 23(13): 2918-25, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15860850
16.
PET concerns in bevacizumab treatment.
Nat Med
; 10(6): 561; author reply 561, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15170192
17.
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer.
Eur Urol
; 68(1): 42-50, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449207
18.
Noninvasive molecular detection of cancer -- the bench and the bedside.
Curr Med Chem
; 10(8): 691-706, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12678787
19.
Diagnostic potential of circulating nucleic acids for oncology.
Expert Rev Mol Diagn
; 3(4): 431-42, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12877383
20.
Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Oncol Rep
; 9(3): 545-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11956625